Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims

Journal of Affective Disorders

Volumn 151, Issue 3, 2013, Pages 924-931

  Sowa Kućma, Magdalena ^a   Szewczyk, Bernadeta ^a   Sadlik, Krystyna ^b   Piekoszewski, Wojciech ^c   Trela, Franciszek ^d   Opoka, Włodzimierz ^d   Poleszak, Ewa ^e   Pilc, Andrzej ^a,d   Nowak, Gabriel ^a,d  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INSTITUTE OF FORENSIC RESEARCH   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Depression; Hippocampus; Magnesium; NMDA receptor; Suicide; Zinc

Indexed keywords

DIZOCILPINE; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; POSTSYNAPTIC DENSITY PROTEIN 95; ZINC;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SUDDEN DEATH; SUICIDE; VICTIM; WESTERN BLOTTING;

DEPRESSION; HIPPOCAMPUS; MAGNESIUM; NMDA RECEPTOR; SUICIDE; ZINC;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; DIZOCILPINE MALEATE; FEMALE; HIPPOCAMPUS; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; N-METHYLASPARTATE; RADIOLIGAND ASSAY; RECEPTORS, N-METHYL-D-ASPARTATE; SUICIDE; YOUNG ADULT; ZINC;

EID: 84886727136     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.08.009     Document Type: Article

References (102)

1. C.M. Banki, M. Vojnik, Z. Papp, K.Z. Balla, and M. Arato Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts Biological Psychiatry 20 1985 163 171
2. R.M. Berman, A. Cappiello, A. Anand, D.A. Oren, G.R. Heninger, D.S. Charney, and J.H. Krystal Antidepressant effects of ketamine in depressed patients Biological Psychiatry 4 2000 351 354
3. R. Bottlender, M. Jäger, A. Strauss, and H.J. Möller Suicidality in bipolar compared to unipolar depressed inpatients European Archives of Psychiatry and Clinical Neuroscience 250 2000 257 261
4. L. Brådvik The occurrence of suicide in severe depression related to the months of the year and the days of the week European Archives of Psychiatry and Clinical Neuroscience 252 2002 28 32
5. L. Brådvik, and M. Berglund Suicide in severe depression related to treatment: depressive characteristics and rate of antidepressant overdose European Archives of Psychiatry and Clinical Neuroscience 255 2005 245 250
6. G. Camardese, L. De Risio, G. Pizi, B. Mattioli, F. Buccelletti, R. Serrani, B. Leone, A. Sgambato, P. Bria, and L. Janiri Plasma magnesium levels and treatment outcome in depressed patients Nutritional Neuroscience 15 2012 78 84
7. A. Cichy, M. Sowa-Kućma, B. Legutko, L. Pomierny-Chamioło, A. Siwek, A. Piotrowska, B. Szewczyk, E. Poleszak, A. Pilc, and G. Nowak Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors Pharmacological Reports 61 2009 1184 1191
8. K. Cieslik, B. Klen-Majewska, Z. Danilczuk, A. Wrobel, and T. Lupina Influence of zinc supplementation on imipramine effect in a chronic unpredictable stress (CUS) model in rats Pharmacological Reports 59 2007 46 52
9. M.P. Cunha, D.G. Machado, L.E. Bettio, J.C. Capra, and A.L. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 2008 1913 1920
10. B. Dean, G. Pavey, M. McLeod, K. Opeskin, N. Keks, and D. Copolov A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder Journal of Affective Disorders 66 2001 147 158
11. S. Decollogne, A. Tomas, C. Lecerf, E. Adamowicz, and M. Seman NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801 Pharmacology Biochemistry and Behavior 58 1997 261 268
12. R.S. Duman, and B. Voleti Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents Trends in Neurosciences 35 2012 47 56
13. G.A. Eby, and K.L. Eby Rapid recovery from major depression using magnesium treatment Medical Hypotheses 67 2006 362 370
14. G.A. Eby, and K.L. Eby Magnesium for treatment-resistant depression: a review and hypothesis Medical Hypotheses 74 2010 649 660
15. A.M. Feyissa, A. Chandran, C.A. Stockmeier, and B. Karolewicz Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 2009 70 75
16. A. Frazer, T.A. Ramsey, A. Swann, C. Bowden, D. Brunswick, D. Garver, and S. Secunda Plasma and erythrocyte electrolytes in affective disorders Journal of Affective Disorders 5 1983 103 113
17. R.D. Gibbons, K. Hur, D.K. Bhaumik, and J.J. Mann The relationship between antidepressant medication use and rate of suicide Archives of General Psychiatry 62 2005 165 172
18. C.R. Hansen Jr.; M. Malecha, T.B. Mackenzie, and J. Kroll Cooper and zinc deficiencies in association with depression and neurological findings Biological Psychiatry 18 1983 395 401
19. K. Hashimoto Emerging role of glutamate in the pathophysiology of major depressive disorder Brain Research Reviews 61 2009 105 123
20. N. Hashizume, and M. Mori An analysis of hypermagnesemia and hypomagnesemia Japanese Journal of Medicine 29 1990 368 372
21. C.J. Hatton, and P. Paoletti Modulation of triheteromeric NMDA receptors by N-terminal domain ligands Neuron 46 2005 261 274
22. K. Hawton, and K. van Heeringen Suicide Lancet 373 2009 1372 1381
23. S. Holemans, F. De Paermentier, R.W. Horton, M.R. Crompton, C.L. Katona, and J.M. Maloteaux NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides Brain Research 616 1993 138 143
24. Y. Imada, S. Yoshioka, T. Ueda, S. Katayama, Y. Kuno, and R. Kawahara Relationships between serum magnesium levels and clinical background factors in patients with mood disorders Psychiatry and Clinical Neurosciences 56 2002 509 514
25. D.V. Iosifescu, N.R. Bolo, A.A. Nierenberg, J.E. Jensen, M. Fava, and P.F. Renshaw Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder Biological Psychiatry 63 2008 1127 1134
26. F.N. Jacka, S. Overland, R. Stewart, G.S. Tell, I. Bjelland, and A. Mykletun Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study Australian and New Zealand Journal of Psychiatry 43 2009 45 52
27. B. Karolewicz, K. Szebeni, T. Gilmore, D. Maciag, C.A. Stockmeier, and G.A. Ordway Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression International Journal of Neuropsychopharmacology 12 2009 143 153
28. G.K. Kirov, N.J. Birch, P. Steadman, and R.G. Ramsey Plasma magnesium levels in a population of psychiatric patients: correlations with symptoms Neuropsychobiology 30 1994 73 78
29. B. Kroczka, P. Branski, A. Pałucha, A. Pilc, and G. Nowak Antidepressant-like properties of zinc in rodent forced swim test Brain Research Bulletin 55 2001 297 300
30. B. Kroczka, A. Zieba, D. Dudek, A. Pilc, and G. Nowak Zinc exhibits an antidepressant-like effect in the forced swimming test in mice Polish Journal of Pharmacology 52 2000 403 406
31. A. Kugaya, and G. Sanacora Beyond monoamines: glutamatergic function in mood disorders CNS Spectrums 10 2005 808 819
32. J. Lai, A. Moxey, G. Nowak, K. Vashum, K. Bailey, and M. McEvoy The efficacy of zinc supplementation as therapy for depression: systematic review of randomized controlled trials Journal of Affective Disorders 136 2012 e31 e39
33. T. Lopes, P. Neubauer, and K.M. Boje Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test Pharmacology Biochemistry and Behavior 58 1997 1059 1064
34. M. Maes, N. De Vos, P. Demedts, and A. Wauters Lower serum zinc in major depression in relation to changes in serum acute phase proteins Journal of Affective Disorders 56 1999 189 194
35. M. Maes, P.C. D'Haese, S. Scharpé, P. D'Hondt, P. Cosyns, and M.E. De Broe Hypozincemia in depression Journal of Affective Disorders 31 1994 135 140
36. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, H.Y. Meltzer, and C. Altamura Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biological Psychiatry 42 1997 349 358
37. C. Martinez, S. Rietbrock, L. Wise, D. Ashby, J. Chick, J. Moseley, S. Evans, and D. Gunnell Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study British Medical Journal 330 2005 389 396
38. D.C. Mathews, I.D. Henter, and C.A. Zarate Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Drugs 72 2012 1313 1333
39. I.J. McLoughlin, and J.S. Hodge Zinc in depressive disorder Acta Psychiatrica Scandinavica 82 1990 451 453
40. J.H. Meador-Woodruff, A.J. Hogg Jr.; and R.E. Smith Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder Brain Research Bulletin 55 2001 631 640
41. K. Młyniec, C.L. Davies, B. Budziszewska, W. Opoka, W. Reczyński, M. Sowa-Kućma, U. Doboszewska, A. Pilc, and G. Nowak Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test Pharmacological Reports 64 2012 567 575
42. K. Młyniec, and G. Nowak Zinc deficiency induces behavioral alterations in the tail suspension test in mice. effect of antidepressants Pharmacological Reports 64 2012 249 255
43. H. Murck Magnesium and affective disorders Nutritional Neuroscience 5 2002 375 389
44. H. Murck Ketamine, magnesium and major depression - from pharmacology to pathophysiology and back Journal of Psychiatric Research 47 2013 955 965
45. A. Muroyama, M. Inaka, H. Matsushima, H. Sugino, Y. Marunaka, and Y. Mitsumoto Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice Neuroscience Research 63 2009 72 75
46. G. Nowak Calcium antagonists in the olfactory bulbectomy animal model of depression: effect on the cortical NMDA receptor complex Polish Journal of Pharmacology 48 1996 137 143
47. G. Nowak, G.A. Ordway, and I.A. Paul Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims Brain Research 675 1995 157 164
48. G. Nowak, G. Ossowska, R. Jopek, and M. Papp Strychnine-insensitive glycine/NMDA sites are altered in two stress models of depression Polish Journal of Pharmacology 50 1998 365 369
49. G. Nowak, A. Redmond, M. McNamara, and I.A. Paul Swim stress increases the potency of glycine at the N-methyl-d-aspartate receptor complex Journal of Neurochemistry 64 1995 925 927
50. G. Nowak, M. Siwek, D. Dudek, A. Zieba, and A. Pilc Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study Polish Journal of Pharmacology 55 2003 1143 1147
51. G. Nowak, B. Szewczyk, K. Sadlik, W. Piekoszewski, F. Trela, E. Florek, and A. Pilc Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims Polish Journal of Pharmacology 55 2003 455 459
52. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, A. Pilc, K. Sadlik, and W. Piekoszewski Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats Brain Research Bulletin 61 2003 159 164
53. G. Nowak, R. Trullas, R.T. Layer, P. Skolnick, and I.A. Paul Adaptive changes in the N-methyl-d-aspartate receptor complex following chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid Journal of Pharmacology and Experimental Therapeutics 265 1993 1380 1386
54. G. Nowak, A. Ziȩba, D. Dudek, M. Krośniak, M. Szymaczek, and M. Schlegel-Zawadzka Serum trace elements in animal models and human depression Part I. Zinc Human Psychopharmacology: Clinical and Experimental 14 1999 83 86
55. A.M. Palmer, M.A. Burns, V. Arango, and J.J. Mann Similar effects of glycine, zinc and an oxidizing agent on [3H]dizocilpine binding to the N-methyl-d-aspartate receptor in neocortical tissue from suicide victims and controls Journal of Neural Transmission: General Section 96 1994 1 8
56. E. Panconi, J. Roux, M. Altenbaumer, S. Hampe, and R.D. Porsolt MK-801 and enantiomers: potential antidepressants or false positives in classical screening models? Pharmacology Biochemistry and Behavior 46 1993 15 20
57. P. Paoletti, and J. Neyton NMDA receptor subunits: function and pharmacology Current Opinion in Pharmacology 7 2007 39 47
58. I.A. Paul, R.T. Layer, P. Skolnick, and G. Nowak Adaptation of the NMDA receptor complex in the rat frontal cortex following chronic treatment with electroconvulsive shock or imipramine European Journal of Pharmacology: Molecular Pharmacology Section 247 1993 305 311
59. I.A. Paul, G. Nowak, R.T. Layer, P. Popik, and P. Skolnick Adaptation of the NMDA receptor complex following chronic antidepressant treatments Journal of Pharmacology and Experimental Therapeutics 269 1994 95 102
60. J. Pawlak, M. Dmitrzak-Wȩglarz, M. Skibińska, A. Szczepankiewicz, A. Leszczyńska-Rodziewicz, A. Rajewska-Rager, D. Zaremba, P. Czerski, and J. Hauser Suicide attempts and clinical risk factors in patients with bipolar and unipolar affective disorders General Hospital Psychiatry 35 2013 427 432
61. R.X. Petrie, I.C. Reid, and C.A. Stewart The N-methyl-d-aspartate receptor, synaptic plasticity and depressive disorder. A critical review Pharmacology and Therapeutics 87 2000 11 25
62. A. Pilc, J.M. Wierońska, and P. Skolnick Glutamate-based antidepressants: preclinical psychopharmacology Biological Psychiatry 73 2013 1125 1132 (pii: S0006-3223(13)00092-9)
63. E. Poleszak Modulation of antidepressant-like activity of magnesium by serotonergic system Journal of Neural Transmission 114 2007 1129 1134
64. E. Poleszak, B. Szewczyk, E. Kȩdzierska, P. Wlaz, A. Pilc, and G. Nowak Antidepressant- and anxiolytic-like activity of magnesium in mice Pharmacology Biochemistry and Behavior 78 2004 7 12
65. E. Poleszak, P. Wlaz, E. Kêdzierska, D. Nieoczym, A. Wróbel, S. Fidecka, A. Pilc, and G. Nowak NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice Pharmacology Biochemistry and Behavior 88 2007 158 164
66. E. Poleszak, P. Wlaz, E. Kedzierska, M. Radziwon-Zaleska, A. Pilc, S. Fidecka, and G. Nowak Effects of acute and chronic treatment with magnesium in the forced swim test in rats Pharmacological Reports 57 2005 654 658
67. E. Poleszak, P. Wlaz, B. Szewczyk, E. Kedzierska, E. Wyska, T. Librowski, J. Szymura-Oleksiak, S. Fidecka, A. Pilc, and G. Nowak Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: behavioral and pharmacokinetic studies in mice Pharmacology Biochemistry and Behavior 81 2005 524 529
68. S.H. Preskorn, B. Baker, S. Kolluri, F.S. Menniti, M. Krams, and J.W. Landen An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606 in patients with treatment-refractory major depressive disorder Journal of Clinical Psychopharmacology 28 2008 631 637
69. E. Przegalinski, E. Tatarczynska, and E. Chojnacka-Wojcik Anxiolytic- and antidepressant-like effects of an antagonist at glycine B receptors Polish Journal of Pharmacology 50 1998 349 354
70. Ranjbar, E.; Shams, J.; Sabetkasaej, M.; M-Shirazi, M.; Rashidkhani, B.; Mostafavi, A.; Bornak, E.; Nasrollahzadeh, J. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutritional Neuroscience, 10.1179/1476830513Y.0000000066, in press.
71. H.H. Rasmussen, P.B. Mortensen, and I.W. Jensen Depression and magnesium deficiency International Journal of Psychiatry in Medicine 19 1989 57 63
72. A.O. Rosa, J. Lin, J.B. Calixto, A.R. Santos, and A.L. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behavioural Brain Research 144 2003 87 93
73. N. Ruljancic, M. Mihanovic, I. Cepelak, A. Bakliza, and K.D. Curkovic Platelet serotonin and magnesium concentrations in suicidal and non-suicidal depressed patients Magnesium Research 26 2013 9 17
74. G. Sanacora, D.L. Rothman, G. Mason, and J.H. Krystal Clinical studies implementing glutamate neurotransmission in mood disorders Annals of the New York Academy of Sciences 1003 2003 292 308
75. S.L. Sensi, P. Paoletti, J.Y. Koh, E. Aizenman, A.I. Bush, and M. Hershfinkel The neurophysiology and pathology of brain zinc Journal of Neurosciences 31 2011 16076 16085
76. N. Singewald, C. Sinner, A. Hetzenauer, S.B. Sartori, and H. Murck Magnesium-deficient diet alters depression- and anxiety-related behavior in mice-influence of desipramine and Hypericum perforatum extract Neuropharmacology 47 2004 1189 1197
77. M. Siwek, D. Dudek, I.A. Paul, M. Sowa-Kućma, A. Zieba, P. Popik, A. Pilc, and G. Nowak Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study Journal of Affective Disorders 118 2009 187 195
78. M. Siwek, D. Dudek, M. Schlegel-Zawadzka, A. Morawska, W. Piekoszewski, W. Opoka, A. Zieba, A. Pilc, P. Popik, and G. Nowak Serum zinc level in depressed patients during zinc supplementation of imipramine treatment Journal of Affective Disorders 126 2010 447 452
79. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-d-aspartate receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1996 23 26
80. M. Sowa-Kucma, B. Legutko, B. Szewczyk, K. Novak, P. Znojek, E. Poleszak, M. Papp, A. Pilc, and G. Nowak Antidepressant-like activity of zinc: further behavioral and molecular evidence Journal of Neural Transmission 115 2008 1621 1628
81. A.A. Spasov, I.N. Iezhitsa, M.V. Kharitonova, and M.S. Kravchenko Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet Zh. Vyssh. Nerv. Deiat. Im. I P Pavlova 58 2008 476 485
82. W. Swardfager, N. Herrmann, R.S. McIntyre, G. Mazereeuw, K. Goldberger, D.S. Cha, Y. Schwartz, and K.L. Lanctôt Potential roles of zinc in the pathophysiology and treatment of major depressive disorder Neuroscience and Biobehavioral Reviews 37 2013 911 929
83. B. Szewczyk, P. Branski, J.M. Wieronska, A. Palucha, A. Pilc, and G. Nowak Interaction of zinc with antidepressants in the forced swimming test in mice Polish Journal of Pharmacology 54 2002 681 685
84. B. Szewczyk, R. Kata, and G. Nowak Rise in zinc affinity for the NMDA receptor evoked by chronic imipramine is species-specific Polish Journal of Pharmacology 53 2001 641 645
85. B. Szewczyk, A. Pałucha-Poniewiera, E. Poleszak, A. Pilc, and G. Nowak Investigational NMDA receptor modulators for depression Expert Opinion on Investigational Drugs 21 2012 91 102
86. B. Szewczyk, E. Poleszak, M. Sowa-Kućma, A. Wróbel, S. Slotwiński, J. Listos, P. Wlaź, A. Cichy, A. Siwek, M. Dybała, K. Gołembiowska, A. Pilc, and G. Nowak Involvement of NMDA and AMPA receptors in the antidepressant-like activity of zinc in the forced swim test Amino Acids 39 2010 205 217
87. B. Szewczyk, E. Poleszak, P. Wlaz, A. Wrobel, E. Blicharska, A. Cichy, M. Dybala, A. Siwek, L. Pomierny-Chamiolo, A. Piotrowska, P. Branski, A. Pilc, and G. Nowak The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test Progress in Neuropsychopharmacology and Biological Psychiatry 33 2009 323 329
88. A. Takeda Zinc signaling in the hippocampus and its relation to pathogenesis of depression Molecular Neurobiology 44 2011 166 174
89. H. Tamano, F. Kan, M. Kawamura, N. Oku, and A. Takeda Behavior in the forced swim test and neurochemical changes in the hippocampus in young rats after 2-week zinc deprivation Neurochemistry International 55 2009 536 541
90. N.M. Tassabehji, R.S. Corniola, A. Alshingiti, and C.W. Levenson Zinc deficiency induces depression-like symptoms in adult rats Physiology and Behavior 95 2008 365 369
91. K. Tokita, T. Yamaji, and K. Hashimoto Roles of glutamate signaling in preclinical and/or mechanistic models of depression Pharmacology Biochemistry and Behavior 100 2012 688 704
92. R. Trullas, and P. Skolnick Functional antagonists at the NMDA receptor complex exhibit antidepressant actions European Journal of Pharmacology 185 1990 1 10
93. E.S. Vizi, M. Kisfali, and T. Lorincz Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects Brain Research Bulletin 93 2013 32 38
94. N. Whittle, L. Li, W.Q. Chen, J.W. Yang, S.B. Sartori, G. Lubec, and N. Singewald Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior Amino Acids 40 2011 1231 1248
95. N. Whittle, G. Lubec, and N. Singewald Zinc deficiency induces enhanced depression-like behaviour and altered limbic activation reversed by antidepressant treatment in mice Amino Acids 36 2009 147 158
96. J. Widmer, P. Bovier, F. Karege, Y. Raffin, H. Hilleret, J.M. Gaillard, and R. Tissot Evolution of blood magnesium, sodium and potassium in depressed patients followed for 3 months Neuropsychobiology 26 1992 173 179
97. J. Widmer, J.G. Henrotte, Y. Raffin, P. Bovier, H. Hilleret, and J.M. Gaillard Relationship between erythrocyte magnesium, plasma electrolytes and cortisol, and intensity of symptoms in major depressed patients Journal of Affective Disorders 34 1995 201 209
98. World Health Organization, 2000. Health Systems: Improving Performance. Geneva, Tertiary.
99. T. Yary, S. Aazami, and K. Soleimannejad Dietary intake of magnesium may modulate depression Biological Trace Element Research 151 2013 324 329
100. C.A. Zarate Jr.; J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, D.A. Luckenbaugh, D.S. Charney, and H.K. Manji A-randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression Archives of General Psychiatry 63 2006 856 864
101. C.A. Zarate, J. Quiroz, J. Payne, and H.K. Manji Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders Psychopharmacology Bulletin 36 2002 35 83
102. A. Ziȩba, R. Kata, D. Dudek, M. Schlegel-Zawadzka, and G. Nowak Serum trace elements in animal models and human depression: Part III. Magnesium. Relationship with Copper Human Psychopharmacology: Clinical and Experimental 15 2000 631 635